Generic competition and pricing practices continue to spearhead rise in US pharmaceutical antitrust cases

Dreamin’ of entering a patent settlement agreement in California? What to know about California’s reverse payment law

A Decade of FTC v. Actavis: The Reverse Payment Framework Is Older, but Are Courts Wiser in Applying It

United States: Pharmaceutical Antitrust 2025

The Inefficient Treatment of the Efficiencies Defense

Third Circuit: Pharmaceutical Cases